How many FDA warning letters has Hangzhou Yiqi Biotechnology Co., Ltd received?

Argus HQ has recorded 1 FDA warning letter for Hangzhou Yiqi Biotechnology Co., Ltd.

What FDA recalls has Hangzhou Yiqi Biotechnology Co., Ltd issued?

Argus HQ has not recorded an FDA recall tied to Hangzhou Yiqi Biotechnology Co., Ltd in our current dataset.

Is Hangzhou Yiqi Biotechnology Co., Ltd FDA compliant?

Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 1 warning letter, 0 recalls, and 0 approval records for Hangzhou Yiqi Biotechnology Co., Ltd. Review the linked FDA source records directly before drawing a compliance conclusion.

.hq

company

Hangzhou Yiqi Biotechnology Co., Ltd

Name: FDA Enforcement Actions Against Hangzhou Yiqi Biotechnology Co., Ltd
Creator: Argus HQ
License: https://argushq.ai/methodology

Industry: pharmaceutical

Jurisdiction: US

FDA Warning Letter timeline

V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.

fda_warning_letter · cgmp2026-04-15
Hangzhou Yiqi Biotechnology Co., Ltd — CGMP/Active Pharmaceutical Ingredient (API)/Adulterated (2026-04-15)

Frequently asked questions

How many FDA warning letters has Hangzhou Yiqi Biotechnology Co., Ltd received?: Argus HQ has recorded 1 FDA warning letter for Hangzhou Yiqi Biotechnology Co., Ltd.
What FDA recalls has Hangzhou Yiqi Biotechnology Co., Ltd issued?: Argus HQ has not recorded an FDA recall tied to Hangzhou Yiqi Biotechnology Co., Ltd in our current dataset.
Is Hangzhou Yiqi Biotechnology Co., Ltd FDA compliant?: Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 1 warning letter, 0 recalls, and 0 approval records for Hangzhou Yiqi Biotechnology Co., Ltd. Review the linked FDA source records directly before drawing a compliance conclusion.

Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.